Wird geladen...
Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: from bench to bedside
Colorectal cancers (CRCs) with deficient mismatch repair (dMMR) or microsatellite instability-high (MSI-H) often have sustained responses to immune checkpoint inhibitors (ICIs) including selective monoclonal antibodies against Program Death 1 (PD-1), Programmed Death Ligand 1(PD-L1), and cytotoxic T...
Gespeichert in:
| Veröffentlicht in: | Biochim Biophys Acta Rev Cancer |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7886024/ https://ncbi.nlm.nih.gov/pubmed/33035640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbcan.2020.188447 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|